Friday, January 28, 2022

COVID-19 Can Be Stopped Without Massive Vaccination: Dr. Peter McCullough

COVID-19 can be stopped without massive vaccination, renowned cardiologist and epidemiologist Dr. Peter McCullough told NTD's "Capitol Report" program during the "Defeat the Mandates" march in Washington D.C., on Jan. 23.

According to McCullough, early treatment and natural immunity are safe and effective against COVID-19, but federal health agencies have ignored these in a push for vaccines, the broad use of which is not needed.

The Centers for Disease Control and Prevention stated on its website that according to the COVID-19 Treatment Guidelines published by the National Institutes of Health, "Current clinical management of COVID-19 consists of infection prevention and control measures and supportive care, including supplemental oxygen and mechanical ventilatory support when indicated."

"This basically means that the vaccines broadly used aren't needed. And in fact, we have seen far too many vaccine injuries and now vaccine failures. With the Omicron variant, there's effectively no coverage of these vaccines against the newest form of the virus," McCullough said, adding 22 studies showed vaccines ran out of efficacy after six months.

McCullough gave the example of how ivermectin, a Nobel prize-winning, FDA-approved drug that many studies and doctors claim is effective in treating COVID-19 patients, was dismissed by federal health agencies.

McCullough expressed doubt about the claim that COVID-19 vaccines could reduce hospitalization and deaths.

"All we have at this point of time is bias-confounded, and I think invalid hospitalization data. The U.S. agencies still make the claim that the vaccines protect against hospitalization, whereas we see no evidence of that in the UK, Germany, South Africa, and the rest of the world," McCullough said.

https://www.theepochtimes.com/dr-mccullough-early-treatment-and-natural-immunity-safe-and-effective-no-need-to-broadly-use-covid-19-vaccines_4235673.html?utm_source=partner&utm_campaign=ZeroHedge 

No comments: